Chair, Department of Environmental and Occupational Health at the School of Public Health, Tel Aviv University
Associate Professor, Epidemiology and Preventive Medicine, Tel Aviv University
Director, Hematology Department (Haifa and the Western Galilee), Clalit Health Services – the largest HMO in Israel.
Professor Froom, originally from the United States, is board-certified in both Hematology and Occupational Medicine. He served in the Israeli Air Force Aero Medical Center many years. Prof. Froom holds his medical degree from Creighton University and undergraduate degree from Stanford University, as well as a Masters of Occupational Health from Tel Aviv University.
Known as a world leader in urine analysis testing, Prof. Froom has changed physician behavior toward the finding of microscopic hematuria. As the author of more than 200 peer-reviewed articles, he recently published articles dealing with quantitative risk assessment for divers exposed to polluted water. Throughout his career, he has supervised many graduate and post-graduate students at TAU.
Prof. Froom's four main areas of research:
He conducts applied research into who to test, what to test for, and the clinical utility of such testing.
Since 2005
2012: Paul Froom; Mira Barak. Cessation of dipstick urinalysis reflex testing and physician ordering behavior.
American journal of clinical pathology 2012;137(3):486-9.
2007: Zvi Shimoni; Yael Averbuch; Esther Shir; Tzippi Gottshalk; Dalia Kfir; Mark Niven; Menachem Moshkowitz; Paul Froom. The addition of fiber and the use of continuous infusion decrease the incidence of diarrhea in elderly tube-fed patients in medical wards of a general regional hospital: a controlled clinical trial. Journal of clinical gastroenterology 2007;41(10):901-5.
2007: Zvi Shimoni; Zeev Klein; Paltiel Weiner; Marc Victor Assous; Paul Froom. The use of prednisone in the treatment of trichinellosis. The Israel Medical Association journal : IMAJ 2007;9(7):537-9.
2007: George Habib; Suheil Artul; Nava Ratson; Paul Froom. Household work disability of Arab housewives with rheumatoid arthritis. Clinical rheumatology 2007;26(5):759-63.
2006: Arie Oksenberg; Paul Froom; Samuel Melamed. Dry mouth upon awakening in obstructive sleep apnea.
Journal of sleep research 2006;15(3):317-20.
2006: Arie Oksenberg; Elena Arons; Paul Froom. Does the severity of obstructive sleep apnea predict patients requiring high continuous positive airway pressure? The Laryngoscope 2006;116(6):951-5.
2006: Paul Froom; Zvi Shimoni. Prediction of hospital mortality rates by admission laboratory tests. Clinical chemistry 2006;52(2):325-8.
2006: Navah Z Ratzon; Paul Froom. Postural control in nurses with and without low back pain. Work (Reading, Mass.) 2006;26(2):141-5.
2006: Navah Z Ratzon; Tamara Schejter-Margalit; Paul Froom. Time to return to work and surgeons' recommendations after carpal tunnel release. Occupational medicine (Oxford, England) 2006;56(1):46-50.
2005: Aneta Lazarov; K Nevo; A Pardo; Paul Froom. Self-reported skin disease in hydrotherapists working in swimming pools. Contact dermatitis 2005;53(6):327-31.
2005: Paul Froom; Alexander Neck; Michaela Shir; Rosa Haavis;Mira Barak. Automatic laboratory-initiated reflex testing to identify patients with autoimmune hemolytic anemia. American journal of clinical pathology 2005;124(1):129-32.
2005: Ephraim Philip Lansky; Gregory Harrison; Paul Froom;Wen Jiang. Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Investigational new drugs 2005;23(2):121-2.
2005: Mira Barak; Ronit Weinberger; Jerom Marcusohn; Paul Froom. Harmonization of the Bayer ADVIA Centaur and Abbott AxSYM automated B-type natriuretic peptide assay in patients on hemodialysis. Clinical chemistry and laboratory medicine : CCLM / FESCC 2005;43(5):554-6.
2005: Ephraim Philip Lansky; Wenguo Jiang; Huanbiao Mo; Lou Bravo; Paul Froom; Wei-ping Yu; Neil M Harris; Ishak Neeman;Moray J Campbell. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Investigational new drugs 2005;23(1):11-20.
